Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies

Abstract Background Randomized controlled trials and real-world studies suggest that combination therapy with sodium–glucose transport protein 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) is associated with improvement in fasting plasma glucose (FPG), glycated hemo...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Aftab Ahmad, Hani Sabbour
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2024-03-01
Edice:	Cardiovascular Diabetology
Témata:	Diabetes mellitus Sodium–glucose transport protein 2 inhibitor Glucagon-like peptide-1 receptor agonist Cardiovascular Meta-analysis Observational studies
On-line přístup:	https://doi.org/10.1186/s12933-024-02192-4
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!